171 related articles for article (PubMed ID: 20809466)
41. Hepatitis B immunity in adolescents and necessity for boost vaccination: 23 years after nationwide hepatitis B virus vaccination program in Taiwan.
Lu JJ; Cheng CC; Chou SM; Hor CB; Yang YC; Wang HL
Vaccine; 2009 Nov; 27(47):6613-8. PubMed ID: 19698812
[TBL] [Abstract][Full Text] [Related]
42. Low rates of seroconversion after hepatitis B vaccination in orphanges with high prevalence of virus carriers.
Cernescu C; Ruţă S; Diaconu C; Bleotu C; Grancea C; Truică C; Crăciun D; Nedelcu IN
Rom J Virol; 1998; 49(1-4):73-81. PubMed ID: 10892428
[TBL] [Abstract][Full Text] [Related]
43. Low-dose intramuscular hepatitis B vaccination in medical students: 4-year follow-up.
Erensoy S; Bilgiç A; Arda B; Ozer O
Infection; 2002 Oct; 30(5):303-5. PubMed ID: 12382091
[TBL] [Abstract][Full Text] [Related]
44. Antibody kinetics among 8-10 years old respondents to hepatitis B vaccination in a low endemic country and the effect of a booster dose given 5 or 10 years later.
Gilca V; De Serres G; Boulianne N; De Wals P; Murphy D; Trudeau G; Massé R; Duval B
Vaccine; 2009 Oct; 27(43):6048-53. PubMed ID: 19683086
[TBL] [Abstract][Full Text] [Related]
45. Double-dose accelerated hepatitis B vaccine in patients with end-stage liver disease.
Arslan M; Wiesner RH; Sievers C; Egan K; Zein NN
Liver Transpl; 2001 Apr; 7(4):314-20. PubMed ID: 11303291
[TBL] [Abstract][Full Text] [Related]
46. Response to hepatitis B vaccine in HIV-1-positive subjects who test positive for isolated antibody to hepatitis B core antigen: implications for hepatitis B vaccine strategies.
Gandhi RT; Wurcel A; Lee H; McGovern B; Shopis J; Geary M; Sivamurthy R; Sax PE; Ukomadu C
J Infect Dis; 2005 May; 191(9):1435-41. PubMed ID: 15809901
[TBL] [Abstract][Full Text] [Related]
47. Phase I clinical trial in healthy adults of a nasal vaccine candidate containing recombinant hepatitis B surface and core antigens.
Betancourt AA; Delgado CA; Estévez ZC; Martínez JC; Ríos GV; Aureoles-Roselló SR; Zaldívar RA; Guzmán MA; Baile NF; Reyes PA; Ruano LO; Fernández AC; Lobaina-Matos Y; Fernández AD; Madrazo AI; Martínez MI; Baños ML; Alvarez NP; Baldo MD; Mestre RE; Pérez MV; Martínez ME; Escobar DA; Guanche MJ; Cáceres LM; Betancourt RS; Rando EH; Nieto GE; González VL; Rubido JC
Int J Infect Dis; 2007 Sep; 11(5):394-401. PubMed ID: 17257877
[TBL] [Abstract][Full Text] [Related]
48. Long-term immunogenicity and efficacy of universal hepatitis B virus vaccination in Taiwan.
Lin YC; Chang MH; Ni YH; Hsu HY; Chen DS
J Infect Dis; 2003 Jan; 187(1):134-8. PubMed ID: 12508157
[TBL] [Abstract][Full Text] [Related]
49. [A seroepidemiologic analysis of hepatitis B in Sichuan province].
Du F; Liu QL; Fu QP; Sun L; Ao R; Guan XJ; Liu Y; Wang J; He H; Tong WB; Qin ZY; Fan WJ; Li J; He JL; Fang G
Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Feb; 30(2):139-43. PubMed ID: 19565873
[TBL] [Abstract][Full Text] [Related]
50. [Studies on the status of immune memory after completion of hepatitis B vaccination].
Li YP; Li RC; Fang KX; Li HM; Hu ZY; He P; Wu XY; Zhang R; Liang ZL; Zhuang H
Zhonghua Liu Xing Bing Xue Za Zhi; 2007 Apr; 28(4):319-21. PubMed ID: 17850693
[TBL] [Abstract][Full Text] [Related]
51. [How protective is the immunization against viral hepatitis B prospectively? Seroprevalence study on viral hepatitis B infection].
Bocşan IS; Gocan G; Ursu L; Brumboiu MI; Soşa I; Simionca L; Sava A; Olaru O; Păştina I
Rev Med Chir Soc Med Nat Iasi; 2005; 109(1):124-30. PubMed ID: 16607840
[TBL] [Abstract][Full Text] [Related]
52. Immunogenicity of two paediatric doses of monovalent hepatitis B or combined hepatitis A and B vaccine in 8-10-year-old children.
Duval B; Gîlca V; Boulianne N; Deceuninck G; Rochette L; De Serres G
Vaccine; 2005 Jul; 23(31):4082-7. PubMed ID: 15963363
[TBL] [Abstract][Full Text] [Related]
53. Low levels of awareness, vaccine coverage, and the need for boosters among health care workers in tertiary care hospitals in India.
Sukriti ; Pati NT; Sethi A; Agrawal K; Agrawal K; Kumar GT; Kumar M; Kaanan AT; Sarin SK
J Gastroenterol Hepatol; 2008 Nov; 23(11):1710-5. PubMed ID: 18761556
[TBL] [Abstract][Full Text] [Related]
54. Hepatitis B seroprevalence in Thailand: 12 years after hepatitis B vaccine integration into the national expanded programme on immunization.
Chongsrisawat V; Yoocharoen P; Theamboonlers A; Tharmaphornpilas P; Warinsathien P; Sinlaparatsamee S; Paupunwatana S; Chaiear K; Khwanjaipanich S; Poovorawan Y
Trop Med Int Health; 2006 Oct; 11(10):1496-502. PubMed ID: 17002723
[TBL] [Abstract][Full Text] [Related]
55. Immunity to hepatitis B vaccine among health care workers.
Baghianimoghadam MH; Shadkam MN; Hadinedoushan H
Vaccine; 2011 Mar; 29(15):2727-9. PubMed ID: 21316498
[TBL] [Abstract][Full Text] [Related]
56. Hepatitis B serologic survey and review of immunization records of children, adolescents and adults in Fiji, 2008-2009.
Tsukakoshi T; Samuela J; Rafai EV; Rabuatoka U; Honda S; Kamiya Y; Buerano CC; Morita K
Virol J; 2015 Mar; 12():36. PubMed ID: 25890269
[TBL] [Abstract][Full Text] [Related]
57. Persistence of antibodies to the surface antigen of the hepatitis B virus (anti-HBs) in children subjected to the Expanded Programme on Immunization (EPI), including hepatitis-B vaccine, in Thailand.
Poovorawan Y; Theamboonlers A; Hirsch P; Vimolket T; Sinlaparatsamee S; Chaiear K; Siraprapasiri T; Khwanjaipanich S; Owatanapanich S; Chunsuttiwat S
Ann Trop Med Parasitol; 2000 Sep; 94(6):615-21. PubMed ID: 11064763
[TBL] [Abstract][Full Text] [Related]
58. [Effectiveness of vaccination against hepatitis B in HIV infected children].
Ołdakowska A; Marczyńska M; Szczepańska-Putz M; Kowalik-Mikołajewska B
Przegl Epidemiol; 2004; 58 Suppl 1():129-33. PubMed ID: 15807171
[TBL] [Abstract][Full Text] [Related]
59. [Combination profiles of hepatitis B marks for Chinese in serosurvey in 2006].
Cui FQ; Bi SL; Zhang Y
Zhongguo Yi Miao He Mian Yi; 2009 Aug; 15(4):294-9. PubMed ID: 20077724
[TBL] [Abstract][Full Text] [Related]
60. Immunogenicity and safety of a high-dose hepatitis B vaccine among patients receiving methadone maintenance treatment: A randomized, double-blinded, parallel-controlled trial.
Shi J; Feng Y; Gao L; Feng D; Yao T; Shi S; Zhang Y; Liang X; Wang S
Vaccine; 2017 Apr; 35(18):2443-2448. PubMed ID: 28343774
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
